Mir-Jamal Hosseini Selected Research

Mir-Jamal Hosseini Research Topics

Disease

11	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 10/2012
5	Inflammation (Inflammations) 07/2020 - 01/2017
4	Neoplasms (Cancer) 09/2016 - 03/2009
3	Neuroinflammatory Diseases 06/2022 - 01/2017
3	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 07/2020
3	Mental Disorders (Mental Disorder) 03/2022 - 10/2012
3	Ischemia 01/2022 - 08/2015
3	Mood Disorders (Mood Disorder) 07/2019 - 01/2016
3	Poisoning 07/2019 - 01/2008
2	Cognitive Dysfunction 01/2022 - 05/2021
2	Parkinson Disease (Parkinson's Disease) 10/2020 - 07/2019
2	Wounds and Injuries (Trauma) 07/2019 - 10/2012
2	Body Weight (Weight, Body) 03/2019 - 01/2018
2	Cardiotoxicity 06/2017 - 09/2016
2	Rupture 02/2015 - 02/2013
2	Heart Arrest (Cardiac Arrest) 01/2011 - 01/2009
2	Cardiac Arrhythmias (Arrythmia) 01/2011 - 01/2009
1	Hypoxia (Hypoxemia) 01/2022
1	Stroke (Strokes) 01/2022
1	Schizophrenia (Dementia Praecox) 01/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2020
1	Hemoglobinuria 05/2019
1	Colitis 12/2017
1	Bites and Stings (Sting) 08/2017
1	Scorpion Stings 08/2017
1	Anaphylaxis (Anaphylactic Shock) 08/2017
1	Bipolar Disorder (Manic Depressive Psychosis) 02/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Acute Promyelocytic Leukemia 09/2016
1	Tuberculosis (Tuberculoses) 01/2016
1	Reperfusion Injury 08/2015
1	Infarction (Infarctions) 08/2015
1	Liver Failure 01/2014

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 01/2021 - 01/2011
5	Cytochromes c (Cytochrome c)IBA 04/2019 - 02/2013
4	Adenosine Triphosphate (ATP)IBA 05/2019 - 02/2013
3	Therapeutic UsesIBA 01/2022 - 01/2017
3	Selegiline (E250)FDA LinkGeneric 01/2022 - 07/2019
3	AntioxidantsIBA 07/2019 - 08/2015
2	Cholinergic Agents (Cholinergics)IBA 04/2022 - 07/2020
2	Antidepressive Agents (Antidepressants)IBA 05/2021 - 01/2009
2	Streptozocin (Streptozotocin)FDA Link 08/2020 - 01/2017
2	CytokinesIBA 05/2019 - 01/2007
2	Malondialdehyde (Propanedial)IBA 05/2019 - 08/2015
2	Glutathione (Reduced Glutathione)IBA 04/2019 - 10/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 06/2017
2	LithiumIBA 02/2017 - 10/2012
2	Morphine (MS Contin)FDA LinkGeneric 09/2016 - 01/2007
2	Ouabain (G Strophanthin)IBA 01/2011 - 01/2009
2	Ion Channels (Ion Channel)IBA 01/2011 - 01/2009
1	Metformin (Glucophage)FDA LinkGeneric 06/2022
1	ApigeninIBA 03/2022
1	pyridineIBA 01/2022
1	CurcuminIBA 01/2021
1	Clozapine (Clozaril)FDA LinkGeneric 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	GlucosidesIBA 01/2021
1	alpha-ChlorohydrinIBA 11/2020
1	Methamphetamine (Desoxyn)FDA LinkGeneric 10/2020
1	Minocycline (Cyclops)FDA LinkGeneric 08/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 07/2020
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 07/2019
1	tungstateIBA 04/2019
1	sodium tungstate(VI) (sodium tungstate)IBA 04/2019
1	Food Additives (Food Additive)IBA 03/2019
1	melamineIBA 01/2018
1	2,4-dinitrofluorobenzene sulfonic acidIBA 12/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2017
1	Sulfonic AcidsIBA 12/2017
1	DinitrobenzenesIBA 12/2017
1	NanogelsIBA 08/2017
1	Antivenins (Antivenoms)IBA 08/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2017
1	Membrane LipidsIBA 06/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2017
1	Cytotoxins (Cytolysins)IBA 01/2017
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2017
1	Arsenic Trioxide (Trisenox)FDA Link 09/2016
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2016
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2016
1	AntiemeticsIBA 01/2016
1	HydrazinesIBA 01/2016
1	Tropisetron (Navoban)IBA 01/2016
1	Mitochondrial Permeability Transition PoreIBA 08/2015
1	MB Form Creatine KinaseIBA 08/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2015
1	Vasopressins (Vasopressin)IBA 08/2015
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2015
1	AtractylosideIBA 08/2015
1	ThalliumIBA 02/2015
1	Matrix Metalloproteinases (MMPs)IBA 02/2015
1	Illicit Drugs (Recreational Drugs)IBA 01/2014
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2013
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2013

Therapy/Procedure

3	Therapeutics 10/2020 - 08/2017
1	Oral Administration 01/2022
1	Immunotherapy 08/2017